Liver Carcinoma-related Mortality and Potential Years of Life Lost among Residents in Pudong New Area of Shanghai between 2002 and 2019
Shanghai Pudong New Area Center for Disease Control and Prevention/Fudan University Pudong Institute of Preventive Medicine,Shanghai 200136,China
*Corresponding author:XIAO Shaotan,Associate chief physician;E-mail:stxiao@pdcdc.sh.cn
CHEN Yichen,QU Xiaobin,SUN Lianghong, et al. Liver Carcinoma-related Mortality and Potential Years of Life Lost among Residents in Pudong New Area of Shanghai between 2002 and 2019 [J]. Chinese General Practice, 2021, 24(12): 1517-1522. DOI: 10.12114/j.issn.1007-9572.2021.00.116.
陈亦晨,曲晓滨,孙良红等. 2002—2019年上海市浦东新区居民肝癌死亡特征及减寿率分析[J]. 中国全科医学, 2021, 24(12): 1517-1522. DOI: 10.12114/j.issn.1007-9572.2021.00.116.
[1]GBD 2017 Causes of Death Collaborators.Global,regional,and national age-sex-specifc mortality for 282 causes of death in 195 countries and territories,1980—2017:a systematic analysis for the Global Burden of Disease Study 2017[J].Lancet,2018,392(10159):1736-1788.DOI:10.1016/S0140-6736(18)32203-7.
[2]GBD 2017 Disease and Injury Incidence and Prevalence Collaborators.Global,regional,and national incidence,prevalence,and years lived with disability for 354 diseases and injuries for 195 countries and territories,1990—2017:a systematic analysis for the Global Burden of Disease Study 2017[J].Lancet,2018,392(10159):1789-1858.DOI:10.1016/S0140-6736(18)32279-7.
[3]CHEN W Q,ZHENG R S,BAADE P D,et al.Cancer statistics in China,2015[J].CA:A Cancer J Clin,2016,66(2):115-132.DOI:10.3322/caac.21338.
[4]BRAY F,FERLAY J,SOERJOMATARAM I,et al.Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2018,68(6):394-424.DOI:10.3322/caac.21492.
[5]CHEN H Y,HAO L P,YANG C,et al.Understanding the rapid increase in life expectancy in Shanghai,China:a population-based retrospective analysis[J].BMC Public Heal,2018,18:256.DOI:10.1186/s12889-018-5112-7.
[6]SILVERSMIT G,VAES E,VAN EYCKEN L.Estimation of population-based cancer-specific potential years of life lost in Belgium[J].Eur J Cancer Prev,2017,26:S157-S163.DOI:10.1097/cej.0000000000000385.
[7]沈飞琼,杨金华,李其龙,等.2010—2014年浙江省肿瘤登记地区肝癌发病与死亡分析[J].中国肿瘤,2019,28(10):764-768.DOI:10.11735/j.issn.1004-0242.2019.10.A008.
SHEN F Q,YANG J H,LI Q L,et al.Incidence and mortality of liver cancer in Zhejiang cancer registration areas from 2010 to 2014[J].China Cancer,2019,28(10):764-768.DOI:10.11735/j.issn.1004-0242.2019.10.A008.
[8]FENG R M,ZONG Y N,CAO S M,et al.Current cancer situation in China:good or bad news from the 2018 Global Cancer Statistics?[J].Cancer Commun,2019,39(1):22.DOI:10.1186/s40880-019-0368-6.
[9]陈丽莉,程晓萍,白明宇,等.2013—2018年营口市城市户籍居民恶性肿瘤死因分析[J].中国全科医学,2020,23(27):3427-3432.DOI:10.12114/j.issn.1007-9572.2020.00.375.
CHEN L L,CHENG X P,BAI M Y,et al.Causes of Cancer Death in Urban Residents of Yingkou from 2013 to 2018[J].Chinese General Practice,2020,23(27):3427-3432.DOI:10.12114/j.issn.1007-9572.2020.00.375.
[10]WANG F,MUBARIK S,ZHANG Y,et al.Long-term trends of liver cancer incidence and mortality in China 1990—2017:a joinpoint and age-period-cohort analysis[J].Int J Environ Res Public Heal,2019,16(16):2878.DOI:10.3390/ijerph16162878.
[11]LIU Z,YANG Q,SHI O,et al.The epidemiology of hepatitis B and hepatitis C infections in China from 2004 to 2014:an observational population-based study[J].J Viral Hepat,2018,25(12):1543-1554.DOI:10.1111/jvh.12938.
[12]WANG S,SMITH H,PENG Z,et al.Increasing coverage of hepatitis B vaccination in china:a systematic review of interventions and implementation experiences[J].Medicine (Baltimore),2016,95(19):e3693.DOI:10.1097/MD.0000000000003693.
[13]翟晨,穆蕾,杨悠悠.中国及欧盟粮油食品真菌毒素限量及减控措施对比[J].现代食品科技,2020,36(3):302-309.DOI:10.13982/j.mfst.1673-9078.2020.3.040.
ZHAI C,MU L,YANG Y Y.Comparison of mycotoxins limit standards and control measures of grain and oil foods between China and European union:a review[J].Modern Food Science and Technology,2020,36(3):302-309.DOI:10.13982/j.mfst.1673-9078.2020.3.040.
[14]刘帅,蔡前芳,顾卫英,等.家庭医生责任制模式下开展防止抗生素滥用健康教育的 SWOT 分析[J].中国健康教育,2015,31(10):1005-1007.DOI:10.16168/j.cnki.issn.1002-9982.2015.10.027.
[15]舒之群,荆丽梅,李明,等.上海市浦东新区规范化培训全科医生队伍现状及能力分析[J].中国全科医学,2018,21(28):3508-3512.DOI:10.3969/j.issn.1007-9572.2018.00.042.
SHU Z Q,JING L M,LI M,et al.Demographic and professional analysis of the general practitioner workforce receiving “5+3 ” model of standardized training in Shanghai's Pudong new area[J].Chinese General Practice,2018,21(28):3508-3512.DOI:10.3969/j.issn.1007-9572.2018.00.042.
[16]王临池,胡一河,黄春妍,等.2006—2015年江苏省苏州市肝癌流行趋势与空间分布研究[J].中国肿瘤,2020,29(7):481-485.DOI:10.11735/j.issn.1004-0242.2020.07.A001.
WANG L C,HU Y H,HUANG C Y,et al.Spatial epidemiological and tend analysis of liver cancer in Suzhou,2006—2015[J].China Cancer,2020,29(7):481-485.DOI:10.11735/j.issn.1004-0242.2020.07.A001.
[17]BAECKER A,LIU X,LA VECCHIA C,et al.Worldwide incidence of hepatocellular carcinoma cases attributable to major risk factors[J].Eur J Cancer Prev,2018,27(3):205-212.DOI:10.1097/cej.0000000000000428.
[18]徐继英,李新建,姚海宏,等.上海市成年人慢性病相关危险因素行为特征研究[J].中华预防医学杂志,2013,47(9):821-825.DOI:10.3760/cma.j.issn.0253-9624.2013.09.011.
[19]曹艳,王艳.基于死因监测青岛市居民2008—2012年原发性肝癌死亡分析[J].中华肿瘤防治杂志,2017,24(9):579-583.DOI:10.16073/j.cnki.cjcpt.2017.09.001.
CAO Y,WANG Y.Mortality analysis of primary liver cancer in Qingdao City residents during 2008—2012 based on the cause of death[J].Chinese Journal of Cancer Prevention and Treatment,2017,24(9):579-583.DOI:10.16073/j.cnki.cjcpt.2017.09.001.
[20]杨黎明,李小攀,杨琛,等.2002—2011年上海市浦东新区居民原发性肝癌发病及生存情况分析[J].中华流行病学杂志,2012,33(10):1016-1020.